loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Rofecoxib

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Rofecoxib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tremeau Pharmaceuticals to Host Key Opinion Leader Webinar on Rofecoxib
    Tremeau Pharmaceuticals to Host Key Opinion Leader Webinar on Rofecoxib

    20 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221020005171/en

    BUSINESSWIRE
    20 Oct 2022
    Share Share
    BriOri BioTech Inc. Granted Patent for Topical Formulation of Vioxx
    BriOri BioTech Inc. Granted Patent for Topical Formulation of Vioxx

    09 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220309005277/en

    BUSINESSWIRE
    09 Mar 2022
    Share Share
    BriOri BioTech Inc. Granted Patent for Topical Formulation of Rofecoxib
    BriOri BioTech Inc. Granted Patent for Topical Formulation of Rofecoxib

    15 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220215005470/en

    BUSINESSWIRE
    15 Feb 2022
    Share Share
    Tremeau's Presentations Highlight Unmet Need for Non-Opioid Pain Treatments
    Tremeau's Presentations Highlight Unmet Need for Non-Opioid Pain Treatments

    13 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211213005007/en

    BUSINESSWIRE
    13 Dec 2021
    Share Share
    Could Vioxx Make a Comeback? Recalled Drug Receives Orphan Designation
    Could Vioxx Make a Comeback? Recalled Drug Receives Orphan Designation

    05 Jun 2020

    // Blake N. Shultz PETRIEFLOM

    https://blog.petrieflom.law.harvard.edu/2020/06/05/vioxx-rofecoxib-orphan-drug/

    Blake N. Shultz PETRIEFLOM
    05 Jun 2020
    Share Share
    6 Major Drug Recalls from the Past
    6 Major Drug Recalls from the Past

    17 Oct 2019

    // Charlie Harper BIOSPACE

    https://www.biospace.com/article/6-major-drug-recalls-in-the-past-for-health-concerns/?s=95

    Charlie Harper BIOSPACE
    17 Oct 2019
    Share Share